The preventive Effectiveness of Rituximab in Pediatric Autoimmune and Inflammatory CNS Diseases Relapse: an Iranian Experience

OBJECTIVES: To determine the effectiveness of Rituximab (RTX) therapy as the first therapeutic choice for the long-term prevention of secondary relapse in children with AIND that had relapse after primary treatment with immunosuppressive agents other than RTX. MATERIALS & METHODS: We conducted a...

Descripción completa

Detalles Bibliográficos
Autores principales: NASEHI, Mohammad Mahdi, GHOFRANI, Mohammad, TABRIZI, Aydin, Abdollah GORJI, Fatemeh, KHOSRAVI, Bakhtyar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Shahid Beheshti University of Medical Sciences 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9531201/
https://www.ncbi.nlm.nih.gov/pubmed/36204433
http://dx.doi.org/10.22037/ijcn.v16i3.29322

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9531201/
https://www.ncbi.nlm.nih.gov/pubmed/36204433
http://dx.doi.org/10.22037/ijcn.v16i3.29322

Ejemplares similares